Announce Date | 02/26/2025 |
EPS Normalized Actual | $1.17 (Beat by $0.26) |
EPS GAAP Actual | $1.17 (Beat by $0.26) |
Revenue Actual | $1.08453B |
Revenue Surprise | Beat by $1084.53M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jan 2028 | 13.24 | 10.93 | 12.97859 | 13.48557 | 1 |
Jan 2028 | 13.07 | 11.07 | 12.59119 | 13.67738 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.12 | 1.12 | 1.08453B | 12.18% | 1084.53M |
FQ4 2024 (Oct 2024) | 2.39 | 2.39 | 1.00741B | -12.78% | 1007.41M |
FQ3 2024 (Jul 2024) | 2.35 | 2.35 | 1.20306B | 30.98% | 1203.06M |
FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 1.14242B | 25.3% | 1142.42M |
FQ1 2024 (Jan 2024) | 0.8 | 0.8 | 0.952455B | 100% | 952.46M |
FQ4 2023 (Oct 2023) | 2.85 | 2.85 | 1.13611B | 100% | 1136.11M |
FQ3 2023 (Jul 2023) | 2.05 | 2.05 | 0.830409B | 100% | 830.41M |
FQ2 2023 (Apr 2023) | 1.75 | 1.75 | 0.853366B | 100% | 853.37M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 1.70122 | -- | 1.68305 | 1.73138 | 3 |
FQ4 2026 (Oct 2026) | 3.86755 | -- | 3.82624 | 3.93611 | 3 |
FQ3 2026 (Jul 2026) | 3.2906 | -- | 3.25545 | 3.34893 | 3 |
FQ2 2026 (Apr 2026) | 1.79879 | -- | 1.77957 | 1.83068 | 3 |
FQ1 2026 (Jan 2026) | 1.4157 | 20.89 | 1.38049 | 1.48084 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Jan 2027) | 1.26B | -- | 1.25B | 1.28B | 3 |
FQ4 2026 (Oct 2026) | 1.55B | -- | 1.54B | 1.57B | 3 |
FQ3 2026 (Jul 2026) | 1.48B | -- | 1.47B | 1.5B | 3 |
FQ2 2026 (Apr 2026) | 1.28B | -- | 1.27B | 1.29B | 3 |
FQ1 2026 (Jan 2026) | 1.21B | 10.22 | 1.18B | 1.25B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | 1.12 | 1.12 | 100% | |
FQ4 2024 (Oct 2024) | 2.39 | 2.39 | 100% | |
FQ3 2024 (Jul 2024) | 2.35 | 2.35 | 100% | |
FQ2 2024 (Apr 2024) | 2.15 | 2.15 | 100% | |
FQ1 2024 (Jan 2024) | 0.8 | 0.8 | 100% | |
FQ4 2023 (Oct 2023) | 2.85 | 2.85 | 100% | |
FQ3 2023 (Jul 2023) | 2.05 | 2.05 | 100% | |
FQ2 2023 (Apr 2023) | 1.75 | 1.75 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $1.08B | $1084.53M | 100% |
FQ4 2024 (Oct 2024) | $0B | $1.01B | $1007.41M | 100% |
FQ3 2024 (Jul 2024) | $0B | $1.2B | $1203.06M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.14B | $1142.42M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.95B | $952.46M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.14B | $1136.11M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.83B | $830.41M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.85B | $853.37M | 100% |